Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4634 (MIR4634) is a member of the microRNA family—small (20–24 nucleotide) non-coding RNAs transcribed by RNA polymerase II as part of longer primary transcripts. After sequential cleavage by Drosha and Dicer ribonucleases, mature MIR4634 is loaded into the RNA-induced silencing complex (RISC), where it guides the repression of target mRNAs through imperfect base pairing, most typically resulting in translational inhibition or mRNA destabilization. The MIR4634 gene is listed in key genomic databases (HGNC: 41559, NCBI Gene: 100616202, Ensembl: ENSG00000266890, miRBase: hsa-mir-4634)[3]. MicroRNAs including MIR4634 participate broadly in gene expression regulation but are not considered classical therapeutic targets like receptors, enzymes, or transporters. There are no documented drug interactions, mechanisms of action for drug targeting, or established roles as a biomarker or specific disease involvement for MIR4634 based on current available sources[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4634 (MIR4634).